Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zuogui Wan is a classic Traditional Chinese Medicine (TCM) formula primarily used to nourish kidney yin and replenish essence. It is traditionally indicated for symptoms of kidney yin deficiency, including lower back and knee soreness, night sweats, fatigue, and dry mouth. Modern clinical and preclinical research has explored its efficacy in treating renal osteodystrophy, osteoporosis, premature ovarian failure, and neuroinflammatory conditions like multiple sclerosis. Its mechanism involves modulating bone metabolism, inhibiting the MAPK signaling pathway (specifically ERK1/2, p38, and JNK), and attenuating microglial M1 polarization to promote remyelination. The formula is manufactured by companies such as Shanghai Lei Yun Shang Pharmaceutical and is widely used in integrative medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zuogui wan.